Michael Andreeff
5Patents
2h-index
6Co-inventors
40Inventor score
Filing activity: Nov 28, 2001 → Feb 27, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7435755B2 | CDDO-compounds and combination therapies thereof | Human Necessities | 90 | Expired |
| US7795305B2 | CDDO-compounds and combination therapies thereof | Human Necessities | 56 | Active |
| US6929802B2 | Method of cancer treatment | Human Necessities | 1 | Expired |
| US9846160B2 | Ganglioside GD2 as a marker and target on cancer stem cells | Physics | 0 | Active |
| US7204996B2 | Method of cancer treatment | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.